Cargando…

Hepatic Radioembolization as a Bridge to Liver Surgery

Treatment of oncologic disease has improved significantly in the last decades and in the future a vast majority of cancer types will continue to increase worldwide. As a result, many patients are confronted with primary liver cancers or metastatic liver disease. Surgery in liver malignancies has ste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braat, Arthur J. A. T., Huijbregts, Julia E., Molenaar, I. Quintus, Borel Rinkes, Inne H. M., van den Bosch, Maurice A. A. J., Lam, Marnix G. E. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115667/ https://www.ncbi.nlm.nih.gov/pubmed/25126539 http://dx.doi.org/10.3389/fonc.2014.00199

Ejemplares similares

The physics of radioembolization
por: Bastiaannet, Remco, et al.
Publicado: (2018)

Mode of progression after radioembolization in patients with colorectal cancer liver metastases
por: van Roekel, Caren, et al.
Publicado: (2020)

Radioembolization-Induced Changes in Hepatic [(18)F]FDG Metabolism in Non-Tumorous Liver Parenchyma
por: Braat, Manon N., et al.
Publicado: (2022)

Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients
por: Braat, Manon N. G. J. A., et al.
Publicado: (2017)

Holmium-166 Radioembolization: Current Status and Future Prospective
por: Stella, Martina, et al.
Publicado: (2022)

Feasibility of imaging (90)Y microspheres at diagnostic activity levels for hepatic radioembolization treatment planning
por: Kunnen, Britt, et al.
Publicado: (2020)

The role of (90)Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review
por: Braat, M. N. G. J. A., et al.
Publicado: (2016)

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry
por: Stella, Martina, et al.
Publicado: (2023)

Gamma camera characterization at high holmium-166 activity in liver radioembolization
por: Stella, Martina, et al.
Publicado: (2021)

Accuracy of SPECT/CT‐based lung dose calculation for Holmium‐166 hepatic radioembolization before OSEM convergence
por: van Nierop, Bastiaan J., et al.
Publicado: (2018)

The Effect of Intra-Arterial Angiotensin II on the Hepatic Tumor to Non-Tumor Blood Flow Ratio for Radioembolization: A Systematic Review
por: van den Hoven, Andor F., et al.
Publicado: (2014)

Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol
por: Andel, Daan, et al.
Publicado: (2023)

Quality of life in patients with liver tumors treated with holmium-166 radioembolization
por: van Roekel, Caren, et al.
Publicado: (2019)

The Efficacy of Coil Embolization to Obtain Intrahepatic Redistribution in Radioembolization: Qualitative and Quantitative Analyses
por: Alsultan, Ahmed A., et al.
Publicado: (2019)

Use of C-Arm Cone Beam CT During Hepatic Radioembolization: Protocol Optimization for Extrahepatic Shunting and Parenchymal Enhancement
por: van den Hoven, Andor F., et al.
Publicado: (2015)

Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial
por: Smits, Maarten LJ, et al.
Publicado: (2010)

(166)Holmium–(99)(m)Technetium dual-isotope imaging: scatter compensation and automatic healthy-liver segmentation for (166)Holmium radioembolization dosimetry
por: Stella, Martina, et al.
Publicado: (2022)

Quantitative Comparison of PET and Bremsstrahlung SPECT for Imaging the In Vivo Yttrium-90 Microsphere Distribution after Liver Radioembolization
por: Elschot, Mattijs, et al.
Publicado: (2013)

Liver lymphatic drainage patterns follow segmental anatomy
por: van den Bent, Lotte, et al.
Publicado: (2022)

The Evolving Role of Radioembolization in the Treatment of Neuroendocrine Liver Metastases
por: Ramdhani, Khalil, et al.
Publicado: (2022)

(68)Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with (177)Lu-PSMA-617
por: de Vries, Lisa H., et al.
Publicado: (2020)

Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy
por: Ebbers, Sander C., et al.
Publicado: (2022)

Additional hepatic (166)Ho-radioembolization in patients with neuroendocrine tumours treated with (177)Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)
por: Braat, Arthur J. A. T., et al.
Publicado: (2018)

Use of an anti-reflux catheter to improve tumor targeting for holmium-166 radioembolization—a prospective, within-patient randomized study
por: van Roekel, Caren, et al.
Publicado: (2020)

Reassessment of the lung dose limits for radioembolization
por: Kappadath, S. Cheenu, et al.
Publicado: (2021)

Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with (90)Y-Microspheres for Unresectable Liver Metastases
por: Smits, Maarten L. J., et al.
Publicado: (2013)

Rare Case of an Epithelial Cyst in an Intrapancreatic Accessory Spleen Treated by Robot-Assisted Spleen Preserving Distal Pancreatectomy
por: van Dijck, Willemijn P. M., et al.
Publicado: (2016)

Efficacy and Complications of Nasojejunal, Jejunostomy and Parenteral Feeding After Pancreaticoduodenectomy
por: Gerritsen, Arja, et al.
Publicado: (2012)

Correction: Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with (90)Y-Microspheres for Unresectable Liver Metastases
por: Smits, Maarten L. J., et al.
Publicado: (2013)

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
por: Raval, Mihir, et al.
Publicado: (2014)

Radioembolization of Hepatic Lesions from a Radiobiology and Dosimetric Perspective
por: Cremonesi, Marta, et al.
Publicado: (2014)

Surefire infusion system versus standard microcatheter use during holmium-166 radioembolization: study protocol for a randomized controlled trial
por: van den Hoven, Andor F., et al.
Publicado: (2016)

Invited Commentary: Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation
por: Borel Rinkes, Inne H. M.
Publicado: (2022)

Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response
por: Rosenbaum, C. E. N. M., et al.
Publicado: (2016)

Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
por: Chung, Sung Won, et al.
Publicado: (2023)

Tissue clearing and immunostaining to visualize the spatial organization of vasculature and tumor cells in mouse liver
por: Frenkel, Nicola, et al.
Publicado: (2023)

The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases
por: Smits, Maarten L. J., et al.
Publicado: (2019)

Irreversible Electroporation of the Pancreas Using Parallel Plate Electrodes in a Porcine Model: A Feasibility Study
por: Rombouts, Steffi J. E., et al.
Publicado: (2017)

Adequate symptom relief justifies hepatic resection for benign disease
por: Fioole, Bram, et al.
Publicado: (2005)

Side Effects of Yttrium-90 Radioembolization
por: Riaz, Ahsun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t2n378ck5jiggv410j3p40r81o